Article
Targeted immune epitope prediction to HHLA2 and MAGEB5 protein variants as therapeutic approach to related viral diseases.
BMC immunology - 28 Jul 2021
Achinko Daniel A, Dormer Anton, Narayanan Mahesh, Norman Elton F
Abstract excerpt
BACKGROUND: Targeted immunotherapy is mostly associated with cancer treatment wherein designed molecules engage signaling pathways and mutant proteins critical to the survival of the cell. One of several genetic approaches is the use of in silico methods to develop immune epitopes targeting specific antigenic regions on related mutant proteins. In a recent study we showed a functional association between the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
